+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Leukemia Drugs Market Research Reports

From
Disease Analysis: Acute Myeloid Leukemia (AML) - Product Thumbnail Image

Disease Analysis: Acute Myeloid Leukemia (AML)

  • Report
  • April 2021
  • 120 Pages
  • Global
Market Spotlight: Myelodysplastic Syndrome (MDS) - Product Thumbnail Image

Market Spotlight: Myelodysplastic Syndrome (MDS)

  • Report
  • February 2021
  • 60 Pages
  • Global
From
Venclexta - Product Thumbnail Image

Venclexta

  • Report
  • January 2019
  • 45 Pages
  • Global
From
Treanda/Bendeka - Product Thumbnail Image

Treanda/Bendeka

  • Report
  • January 2019
  • 58 Pages
  • Global
From
Kymriah - Product Thumbnail Image

Kymriah

  • Report
  • January 2019
  • 38 Pages
  • Global
From
Imbruvica - Product Thumbnail Image

Imbruvica

  • Report
  • January 2019
  • 51 Pages
  • Global
From
Gazyva - Product Thumbnail Image

Gazyva

  • Report
  • January 2019
  • 40 Pages
  • Global
From
Arzerra - Product Thumbnail Image

Arzerra

  • Report
  • January 2019
  • 18 Pages
  • Global
From
Pomalyst - Product Thumbnail Image

Pomalyst

  • Report
  • August 2018
  • 21 Pages
  • Global
From
Kyprolis - Product Thumbnail Image

Kyprolis

  • Report
  • August 2018
  • 36 Pages
  • Global
From
Sprycel - API Insight, 2022 - Product Thumbnail Image

Sprycel - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Treanda - API Insight, 2022 - Product Thumbnail Image

Treanda - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Tasigna - API Insight, 2022 - Product Thumbnail Image

Tasigna - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Imbruvica - API Insight, 2022 - Product Thumbnail Image

Imbruvica - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Pomalyst - API Insight, 2022 - Product Thumbnail Image

Pomalyst - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Loading Indicator

The Leukemia Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat leukemia, a type of cancer of the blood and bone marrow. These drugs are used to reduce the number of cancer cells in the body, and to prevent the spread of the disease. Commonly used drugs include chemotherapy, targeted therapy, and immunotherapy. Chemotherapy is a type of drug that works by killing cancer cells. Targeted therapy is a type of drug that works by targeting specific molecules in cancer cells, and immunotherapy is a type of drug that works by stimulating the body's immune system to fight cancer cells. The Leukemia Drugs market is highly competitive, with many companies competing for market share. Some of the major players in the market include Novartis, Pfizer, Bristol-Myers Squibb, Celgene, and Amgen. Show Less Read more